Henan Lingrui Pharmaceutical Co Ltd Financial Flexibility Index
Henan Lingrui Pharmaceutical Co Ltd financial flexibility index. Henan Lingrui Pharmaceutical Co Ltd (600285) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥145.72 Million (operating CF CN¥140.12 Million minus capex CN¥5.61 Million) represents 0% of total liabilities (CN¥2.47 Billion). See 600285 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Financial flexibility index of Henan Lingrui Pharmaceutical Co Ltd from 1999 to 2025. Historical Financial Flexibility Index trend for Henan Lingrui Pharmaceutical Co Ltd across 27 annual periods. Check Henan Lingrui Pharmaceutical Co Ltd (600285) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Henan Lingrui Pharmaceutical Co Ltd Financial Flexibility Index by Year (1999–2025)
Henan Lingrui Pharmaceutical Co Ltd financial flexibility index by year from 1999 to 2025. Year-by-year free cash flow to debt coverage for Henan Lingrui Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Henan Lingrui Pharmaceutical Co Ltd (600285) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.28x | CN¥610.71 Million | CN¥553.88 Million | CN¥2.20 Billion | ▼ -45.7% |
| 2024 | 0.51x | CN¥990.97 Million | CN¥875.86 Million | CN¥1.94 Billion | ▲ +21.0% |
| 2023 | 0.42x | CN¥834.63 Million | CN¥813.43 Million | CN¥1.97 Billion | ▼ -12.4% |
| 2022 | 0.48x | CN¥861.90 Million | CN¥834.91 Million | CN¥1.79 Billion | ▼ -21.2% |
| 2021 | 0.61x | CN¥922.59 Million | CN¥845.69 Million | CN¥1.51 Billion | ▲ +33.1% |
| 2020 | 0.46x | CN¥522.35 Million | CN¥450.53 Million | CN¥1.14 Billion | ▼ -1.1% |
| 2019 | 0.46x | CN¥509.19 Million | CN¥450.15 Million | CN¥1.10 Billion | ▼ -3.3% |
| 2018 | 0.48x | CN¥488.39 Million | CN¥436.25 Million | CN¥1.02 Billion | ▲ +46.0% |
| 2017 | 0.33x | CN¥363.53 Million | CN¥105.97 Million | CN¥1.10 Billion | ▲ +1.8% |
| 2016 | 0.32x | CN¥281.31 Million | CN¥63.26 Million | CN¥869.35 Million | ▲ +32.2% |
| 2015 | 0.24x | CN¥241.05 Million | CN¥156.82 Million | CN¥984.58 Million | ▼ -1.2% |
| 2014 | 0.25x | CN¥226.42 Million | CN¥124.32 Million | CN¥913.70 Million | ▼ -44.1% |
| 2013 | 0.44x | CN¥294.15 Million | CN¥127.27 Million | CN¥663.24 Million | ▲ +128.5% |
| 2012 | 0.19x | CN¥115.96 Million | CN¥15.43 Million | CN¥597.36 Million | ▼ -2.6% |
| 2011 | 0.20x | CN¥104.39 Million | CN¥40.49 Million | CN¥524.02 Million | ▲ +169.7% |
| 2010 | 0.07x | CN¥36.14 Million | CN¥-3.95 Million | CN¥489.25 Million | ▼ -84.3% |
| 2009 | 0.47x | CN¥177.69 Million | CN¥132.61 Million | CN¥378.52 Million | ▲ +154.0% |
| 2008 | 0.18x | CN¥77.35 Million | CN¥43.72 Million | CN¥418.55 Million | ▲ +10.4% |
| 2007 | 0.17x | CN¥60.83 Million | CN¥15.99 Million | CN¥363.31 Million | ▲ +51.5% |
| 2006 | 0.11x | CN¥43.32 Million | CN¥26.76 Million | CN¥392.03 Million | ▼ -17.5% |
| 2005 | 0.13x | CN¥52.58 Million | CN¥33.43 Million | CN¥392.44 Million | ▼ -36.8% |
| 2004 | 0.21x | CN¥76.16 Million | CN¥35.51 Million | CN¥359.36 Million | ▼ -5.0% |
| 2003 | 0.22x | CN¥64.60 Million | CN¥23.79 Million | CN¥289.65 Million | ▼ -49.2% |
| 2002 | 0.44x | CN¥123.47 Million | CN¥69.41 Million | CN¥281.00 Million | ▲ +71.2% |
| 2001 | 0.26x | CN¥40.70 Million | CN¥3.41 Million | CN¥158.59 Million | ▼ -34.1% |
| 2000 | 0.39x | CN¥41.42 Million | CN¥3.66 Million | CN¥106.33 Million | ▲ +321.0% |
| 1999 | 0.09x | CN¥10.45 Million | CN¥4.81 Million | CN¥112.94 Million | — |